Innoviva (INVA) Equity Average: 2009-2025
Historic Equity Average for Innoviva (INVA) over the last 15 years, with Sep 2025 value amounting to $862.4 million.
- Innoviva's Equity Average rose 29.29% to $862.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $862.4 million, marking a year-over-year increase of 29.29%. This contributed to the annual value of $679.9 million for FY2024, which is 4.40% up from last year.
- According to the latest figures from Q3 2025, Innoviva's Equity Average is $862.4 million, which was up 26.66% from $680.9 million recorded in Q2 2025.
- In the past 5 years, Innoviva's Equity Average ranged from a high of $862.4 million in Q3 2025 and a low of $442.8 million during Q3 2021.
- Over the past 3 years, Innoviva's median Equity Average value was $669.0 million (recorded in 2025), while the average stood at $663.4 million.
- Over the last 5 years, Innoviva's Equity Average had its largest YoY gain of 74.40% in 2021, and its largest YoY loss of 13.83% in 2021.
- Innoviva's Equity Average (Quarterly) stood at $508.9 million in 2021, then rose by 18.61% to $603.6 million in 2022, then rose by 7.89% to $651.2 million in 2023, then rose by 4.40% to $679.9 million in 2024, then rose by 29.29% to $862.4 million in 2025.
- Its Equity Average stands at $862.4 million for Q3 2025, versus $680.9 million for Q2 2025 and $669.0 million for Q1 2025.